Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.
Pediatr Neurol
; 85: 71-75, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-30197220
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoglobulins, Intravenous
/
Adrenocorticotropic Hormone
/
Opsoclonus-Myoclonus Syndrome
/
Rituximab
/
Immunologic Factors
/
Immunotherapy
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
Pediatr Neurol
Journal subject:
NEUROLOGIA
/
PEDIATRIA
Year:
2018
Document type:
Article
Country of publication:
United States